Skip to content

Tympanogen

2 viewers · 30d

Total raised

$1.2M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $1.2M
ROUNDS
1
INVESTORS
33
FOUNDED
N/A
HQ
Richmond, VA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Tympanogen, Inc. is a cutting-edge medical device company focused on developing innovative solutions for ear, nose, and throat (ENT) procedures. Their primary aim is to simplify the treatment process for eardrum perforations, providing a more efficient alternative to traditional surgical methods.

What sets it apart

Tympanogen stands out by offering a non-invasive, quick-application solution for eardrum repair, reducing the need for extensive surgical procedures.

Funding history

1 round
EquityFeb 10, 2025 · $10K min
Form D
+$1.2M$1.2M total

Latest SEC filings

via EDGAR · CIK 0001879539
Form D · Feb 10, 2025View on EDGAR

Products

1 tracked

Perf-Fix™

Medical Device

Perf-Fix™ is a novel gel patch specifically designed for the repair of eardrum perforations. This innovative product allows for a straightforward application by healthcare professionals in an outpatient setting without the need for surgery.

  • Non-invasive application
  • Quick procedure that can be completed in a clinic visit
  • Eliminates the need for general anesthesia
  • Minimizes recovery time compared to traditional tympanoplasty

Links

SEC EDGAR filings